134 related articles for article (PubMed ID: 30947375)
21. Synthesis and evaluation of novel 2,3,5-triaryl-4H,2,3,3a,5,6,6a-hexahydropyrrolo[3,4-d]isoxazole-4,6-diones for advanced glycation end product formation inhibitory activity.
Kaur A; Singh B; Jaggi AS
Bioorg Med Chem Lett; 2013 Feb; 23(3):797-801. PubMed ID: 23290454
[TBL] [Abstract][Full Text] [Related]
22. Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency.
Bell IM; Gallicchio SN; Abrams M; Beshore DC; Buser CA; Culberson JC; Davide J; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hartman GD; Heimbrook DC; Homnick CF; Huff JR; Kassahun K; Koblan KS; Kohl NE; Lobell RB; Lynch JJ; Miller PA; Omer CA; Rodrigues AD; Walsh ES; Williams TM
J Med Chem; 2001 Aug; 44(18):2933-49. PubMed ID: 11520202
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase.
Sun L; Bera H; Chui WK
Eur J Med Chem; 2013 Jul; 65():1-11. PubMed ID: 23688695
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and structure elucidation of novel fused 1,2,4-triazine derivatives as potent inhibitors targeting CYP1A1 activity.
El Massry AM; Asal AM; Khattab SN; Haiba NS; Awney HA; Helmy M; Langer V; Amer A
Bioorg Med Chem; 2012 Apr; 20(8):2624-37. PubMed ID: 22414679
[TBL] [Abstract][Full Text] [Related]
25. Stereoselective synthesis and glycosidase inhibitory activity of 3,4-dihydroxy-pyrrolidin-2-one, 3,4-dihydroxy-piperidin-2-one and 1,2-dihydroxy-pyrrolizidin-3-one.
Coutrot P; Claudel S; Didierjean C; Grison C
Bioorg Med Chem Lett; 2006 Jan; 16(2):417-20. PubMed ID: 16271473
[TBL] [Abstract][Full Text] [Related]
26. An overview on natural farnesyltransferase inhibitors for efficient cancer therapy.
Dai X; Sun Y; Zhang T; Ming Y; Hongwei G
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1027-1044. PubMed ID: 32308053
[TBL] [Abstract][Full Text] [Related]
27. Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors.
Qian Y; Marugan JJ; Fossum RD; Vogt A; Sebti SM; Hamilton AD
Bioorg Med Chem; 1999 Dec; 7(12):3011-24. PubMed ID: 10658608
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of homofarnesoyl-substituted CAAX-peptidomimetics as farnesyltransferase inhibitors and antiproliferative agents.
Schlitzer M; Sattler I; Dahse HM
Bioorg Med Chem; 1999 Sep; 7(9):2037-45. PubMed ID: 10530953
[TBL] [Abstract][Full Text] [Related]
29. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors.
Borzilleri RM; Cai ZW; Ellis C; Fargnoli J; Fura A; Gerhardt T; Goyal B; Hunt JT; Mortillo S; Qian L; Tokarski J; Vyas V; Wautlet B; Zheng X; Bhide RS
Bioorg Med Chem Lett; 2005 Mar; 15(5):1429-33. PubMed ID: 15713401
[TBL] [Abstract][Full Text] [Related]
31. 4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate.
Wood J; Bagi CM; Akuche C; Bacchiocchi A; Baryza J; Blue ML; Brennan C; Campbell AM; Choi S; Cook JH; Conrad P; Dixon BR; Ehrlich PP; Gane T; Gunn D; Joe T; Johnson JS; Jordan J; Kramss R; Liu P; Levy J; Lowe DB; McAlexander I; Natero R; Redman AM; Scott WJ; Town C; Wang M; Wang Y; Zhang Z
Bioorg Med Chem Lett; 2006 Sep; 16(18):4965-8. PubMed ID: 16806919
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of pyrazolo[4,3-e][1,2,4]triazine sulfonamides, novel Sildenafil analogs with tyrosinase inhibitory activity.
Mojzych M; Dolashki A; Voelter W
Bioorg Med Chem; 2014 Dec; 22(23):6616-6624. PubMed ID: 25456386
[TBL] [Abstract][Full Text] [Related]
33. Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors.
Schlitzer M
Curr Pharm Des; 2002; 8(19):1713-22. PubMed ID: 12171543
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of imidazole-containing analogues of farnesyl pyrophosphate and evaluation of their biological activity on protein farnesyltransferase.
Coudray L; de Figueiredo RM; Duez S; Cortial S; Dubois J
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):972-85. PubMed ID: 19555171
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of 1,2,4-methyltriazines as mGluR5 antagonists.
Olson JP; Gichinga MG; Butala E; Navarro HA; Gilmour BP; Carroll FI
Org Biomol Chem; 2011 Jun; 9(11):4276-86. PubMed ID: 21503289
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.
Gilleron P; Wlodarczyk N; Houssin R; Farce A; Laconde G; Goossens JF; Lemoine A; Pommery N; Hénichart JP; Millet R
Bioorg Med Chem Lett; 2007 Oct; 17(19):5465-71. PubMed ID: 17827015
[TBL] [Abstract][Full Text] [Related]
37. N4-phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease.
Huang W; Zheng W; Urban DJ; Inglese J; Sidransky E; Austin CP; Thomas CJ
Bioorg Med Chem Lett; 2007 Nov; 17(21):5783-9. PubMed ID: 17827006
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity.
Dao P; Jarray R; Le Coq J; Lietha D; Loukaci A; Lepelletier Y; Hadj-Slimane R; Garbay C; Raynaud F; Chen H
Bioorg Med Chem Lett; 2013 Aug; 23(16):4552-6. PubMed ID: 23845217
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro evaluation of 1,2,4-triazolo[1,5-a][1,3,5]triazine derivatives as thymidine phosphorylase inhibitors.
Bera H; Dolzhenko AV; Sun L; Dutta Gupta S; Chui WK
Chem Biol Drug Des; 2013 Sep; 82(3):351-60. PubMed ID: 23758794
[TBL] [Abstract][Full Text] [Related]
40. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
